ADC Therapeutics initiates financial restructuring with an $86.6 million PIPE financing set to close on October 22, 2026, while amending royalty financing to eliminate a $150 million change-of-control payment.

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.